Averill Madison Master Fund, Ltd.
10% Owner at Benitec Biopharma Inc. (BNTC)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-9.4%
vs. S&P 500-5.4%
Beat the market0%
Paper profit on buys−$130K
Total bought / sold$539K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 22SEC | BNTCBenitec Biopharma Inc. | Buy | 8,7009,546,875 held (+0%) | $11.24 | $98K | -21.1% |
| Dec 22SEC | BNTCBenitec Biopharma Inc. | Buy | 1,5151,821,327 held (+0%) | $11.24 | $17K | -21.1% |
| Dec 22SEC | BNTCBenitec Biopharma Inc. | Buy | 13,9509,560,825 held (+0%) | $11.48 | $160K | -22.7% |
| Dec 22SEC | BNTCBenitec Biopharma Inc. | Buy | 2,4341,823,761 held (+0%) | $11.48 | $28K | -22.7% |
| Dec 22SEC | BNTCBenitec Biopharma Inc. | Buy | 16,6509,577,475 held (+0%) | $12.08 | $201K | -26.6% |
| Dec 22SEC | BNTCBenitec Biopharma Inc. | Buy | 2,8921,826,653 held (+0%) | $12.08 | $35K | -26.6% |
- Buy
10% Owner Averill Madison Master Fund, Ltd. bought $98K of BNTC at $11.24 — first open-market purchase in our records.
- Buy
10% Owner Averill Madison Master Fund, Ltd. bought $160K of BNTC at $11.48 — largest purchase by this insider in our records.
- Buy
10% Owner Averill Madison Master Fund, Ltd. bought $201K of BNTC at $12.08 — largest purchase by this insider in our records.